Efficacy of low-dose hCG in late follicular phase in controlled ovarian stimulation using GnRH agonist protocol

Archives of Gynecology and Obstetrics

Volumn 286, Issue 3, 2012, Pages 771-775

  Aflatoonian, Abbas ^a   Yousefnejad, Fariba ^a   Eftekhar, Maryam ^a   Mohammadian, Farnaz ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ART cycles; GnRH long protocol; Late follicular phase; Low dose hCG; Pregnancy outcome

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED OVARIAN STIMULATION; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; FEMALE; FEMALE INFERTILITY; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HUMAN; INFERTILITY THERAPY; LATE FOLLICULAR PHASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MONOTHERAPY; OOCYTE DEVELOPMENT; OVARY FOLLICLE MATURATION; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MENOTROPINS; OVULATION INDUCTION; PREGNANCY; PROSPECTIVE STUDIES; TRIPTORELIN PAMOATE; YOUNG ADULT;

EID: 84867999816     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2337-z     Document Type: Article

References (20)

1. Blockeel C et al (2009) Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study. Hum Reprod 24(11):2910-2916
2. Serafini P et al (2006) Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: A prospective, randomized trial. Fertil Steril 86(4):830-838 (Pubitemid 44485029)
3. Kenigsberg D et al (2006) Efficacy of luteinizing hormone activity in patients undergoing in vitro fertilization and treated only with low-dose recombinant choriogonadotropin alfa (Ovidrel) in the late follicular phase. Fertil Steril 86(4):1023-1025 (Pubitemid 44485051)
4. Filicori M et al (2002) Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 87(3):1156-1161 (Pubitemid 36121081)
5. Gomes MKO et al (2007) Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG. Eur J Obstet Gynecol Reprod Biol 130(1):99-106 (Pubitemid 44920443)
6. Filicori M et al (2005) Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 84(2):394-401 (Pubitemid 41125260)
7. Cavagna M et al (2010) Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression. Fertil Steril 94(1):167-172
8. Koichi K et al (2006) Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol. J Assist Reprod Genet 23(5):223-228 (Pubitemid 43988389)
9. Van Horne AK et al (2007) Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in vitro fertilization. Fertil Steril 88(4):1010-1013 (Pubitemid 47498384)
10. Nyboe Andersen A et al (2008) Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. Hum Reprod 23(2): 427-434 (Pubitemid 351651237)
11. Campbell B et al (1999) Examination of the relative role of FSH and LH in the mechanism of ovulatory follicle selection in sheep. Reproduction 117(2):355
12. Filicori M et al (1999) Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 84(8):2659-2663 (Pubitemid 30641989)
13. Filicori M et al (2002) The use of LH activity to drive folliculogenesis: Exploring uncharted territories in ovulation induction. Hum Reprod Update 8(6):543-557 (Pubitemid 35452780)
14. Stokman P et al (1993) Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil Steril 60(1):175
15. The European Recombinant LH Study Group and TERLS Group (2001) Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: Results of a multicenter double-blind study. J Clin Endocrinol Metab 86(6):2607-2618
16. Sullivan MW et al (1999) Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): A role for LH in the final stages of follicular maturation. J Clin Endocrinol Metab 84(1):228-232 (Pubitemid 29036707)
17. Blockeel C et al (2011) Gene expression profile in the endometrium on the day of oocyte retrieval after ovarian stimulation with low-dose hCG in the follicular phase. Mol Hum Reprod 17(1):33-41
18. Kyono K et al (2004) A prospective randomized study of three ovulation induction protocols for IVF: GnRH agonist versus antagonist with and without low dose hCG. Fertil Steril 82:S31
19. Kosmas IP et al (2009) Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: A meta-analysis. Reprod BioMed Online 19(5):619-630
20. Verberg MFG et al (2009) Mild ovarian stimulation for IVF. Hum Reprod Update 15(1):13-29